Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world effectiveness of antipsychotic treatments in 1011 acutely hospitalized patients with schizophrenia: A one-year follow-up study.
Hatta K, Katayama S, Ishizuka T, Sudo Y, Nakamura M, Hasegawa H, Imai A, Morikawa F, Shimada T, Misawa F, Ozaki S, Fujita K, Watanabe H, Nakamura H, Sugiyama N; JAST study group. Hatta K, et al. Among authors: fujita k. Asian J Psychiatr. 2022 Jan;67:102917. doi: 10.1016/j.ajp.2021.102917. Epub 2021 Nov 6. Asian J Psychiatr. 2022. PMID: 34875558 Free article.
Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.
Kishi T, Fujita K, Furukawa O, Suzuki T, Moriwaki M, Nitta M, Hattori M, Tsunoka T, Chekuri R, Kane JM, Correll CU, Iwata N. Kishi T, et al. Among authors: fujita k. Asian J Psychiatr. 2013 Jun;6(3):200-7. doi: 10.1016/j.ajp.2012.10.007. Epub 2012 Nov 30. Asian J Psychiatr. 2013. PMID: 23642976 Clinical Trial.
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: fujita k. Schizophr Res. 2014 Sep;158(1-3):213-22. doi: 10.1016/j.schres.2014.07.015. Epub 2014 Jul 31. Schizophr Res. 2014. PMID: 25086659 Free article. Clinical Trial.
A prospective naturalistic multicenter study on choice of parenteral medication in psychiatric emergency settings in Japan.
Hatta K, Katayama S, Morikawa F, Imai A, Fujita K, Fujita A, Ishizuka T, Abe T, Sudo Y, Hashimoto K, Usui C, Nakamura H, Yamanouchi Y, Hirata T; JAST study group. Hatta K, et al. Among authors: fujita k, fujita a. Neuropsychopharmacol Rep. 2018 Sep;38(3):117-123. doi: 10.1002/npr2.12015. Epub 2018 May 24. Neuropsychopharmacol Rep. 2018. PMID: 30175524 Free PMC article.
Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.
Hatta K, Hasegawa H, Imai A, Sudo Y, Morikawa F, Katayama S, Watanabe H, Ishizuka T, Nakamura M, Misawa F, Fujita K, Ozaki S, Umeda K, Nakamura H, Sawa Y, Sugiyama N; JAST study group. Hatta K, et al. Among authors: fujita k. Asian J Psychiatr. 2019 Feb;40:82-87. doi: 10.1016/j.ajp.2019.02.005. Epub 2019 Feb 8. Asian J Psychiatr. 2019. PMID: 30772732
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study.
Niitsu T, Hata T, Nishimoto M, Hosoda Y, Kimura A, Oda Y, Suzuki M, Takase N, Seki R, Fujita K, Endo M, Yoshida T, Inoue M, Hattori N, Murakami T, Imamura Y, Ogawa K, Fukami G, Sato T, Kawasaki Y, Hashimoto T, Ishikawa M, Shiina A, Kanahara N, Iyo M; ROADS Study Group. Niitsu T, et al. Among authors: fujita k. Asian J Psychiatr. 2020 Oct;53:102369. doi: 10.1016/j.ajp.2020.102369. Epub 2020 Aug 31. Asian J Psychiatr. 2020. PMID: 32920492 Free article. Clinical Trial.
Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study.
Ishigooka J, Nakagome K, Ohmori T, Iwata N, Inada K, Iga JI, Kishi T, Fujita K, Kikuchi Y, Shichijo T, Tabuse H, Koretsune S, Terada H, Terada H, Kishimoto T, Tsutsumi Y, Kanda Y, Ohi K, Sekiyama K. Ishigooka J, et al. Among authors: fujita k. Psychiatry Clin Neurosci. 2022 Jan;76(1):22-31. doi: 10.1111/pcn.13304. Epub 2021 Nov 17. Psychiatry Clin Neurosci. 2022. PMID: 34626144 Free PMC article. Clinical Trial.
5,079 results